Silexion Therapeutics (SLXN) Live Share Price, Invest From India

Silexion Therapeutics Stock Performance

as on August 20, 2026 at 3:07 am IST

Day's Low
Day's High
$0.40
Day's Price Range
$0.41
$0.41
1.82%
Downside
0.64%
Upside
52 Week's Low
52 Week's High
$0.37
52-Week Price Range
$80.00
$0.41
8.44%
Downside
19536.72%
Upside

Silexion Therapeutics share price movements today

Previous Close: $0.42
Open: $0.40
Volume: 207.1K
Market Cap: $566.9K
Day's Low - High: $0.40 - $0.41
52 Week Low - High: $0.37 - $80.00

Silexion Therapeutics Historical Returns

1 Month Return: -83.71 %
3 Month Return: -85.46 %
1 Year Return: -99.42 %
3 Year Return: 0 %
5 Year Return: 0 %

Silexion Therapeutics Stock Fundamentals & Key Indicators

Check Silexion Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$566.9K

EPS (TTM)

-5.31

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-897.46%

Silexion Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Silexion Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Silexion Therapeutics	Neutral	$566.9K	NA	NA	0.00%	NA
Revolution Medicines	BUY	$43.7B	669.3%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$128.2B	154.86%	29.82	86.04%	NA
Regeneron	BUY	$82.7B	24.1%	19.24	84.86%	0.44999999999999996%

Stock Returns calculator for Silexion Therapeutics Stock including INR - Dollar returns

The Silexion Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Silexion Therapeutics investment value today

Current value as on today

₹619

Returns

-₹99,381

(-99.38%)

Returns from Silexion Therapeutics Stock

-₹99,437 (-99.44%)

Dollar Impact

₹56 (+0.06%)

Analyst Recommendation on Silexion Therapeutics Stock

Based on 1 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Indian Investors' Interest in Silexion Therapeutics Stock

Search interest for Silexion Therapeutics Stock has increased by 121% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 20, 2026 to August 19, 2026

Change:121% versus previous 30 day period

Silexion Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	-	0	0	-	0	0	0	0	0
Operating Income	-1	-1	-8	-1	-1	-2	-3	18	-2
EBITDA	-1	-1	-11	-1	-1	-2	-3	-4	-2
Interest Expense	-	0	0	-	0	-	0	0	-
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	-11	-1	-1	-2	-3	-4	-2
Income Tax Expense	0	0	0	0	-	0	-	-	-
Net Income	-1	-1	-11	-1	-1	-2	-3	-4	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Silexion Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	0	0
Operating Income	-3	-4	-12	11
EBITDA	-3	-5	-16	-11
Interest Expense	0	0	0	0
Depreciation	0	0	0	0
Income Before Tax	-3	-5	-16	-11
Income Tax Expense	0	0	0	0
Net Income	-3	-4	-16	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Silexion Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-1	-11	-1	-1	-2	-3	-4	-2	-3
Operating Cash Flow	-1	-2	-2	-2	-2	-2	-3	-3	-2
Investing Cash Flow	-	0	-	0	0	-	0	-	0
Financing Cash Flow	-	2	2	7	0	8	0	0	2
Change in Cash	-1	0	0	4	-2	5	-3	-3	0

Silexion Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	0	0	-3	-5	-16	-11
Operating Cash Flow	0	-1	-3	-4	-8	-10
Investing Cash Flow	-	-	0	0	0	0
Financing Cash Flow	0	116	2	0	5	15
Change in Cash	0	0	-1	-3	-3	4

Global Institutional Holdings in Silexion Therapeutics

Funds	Holdings
JONES FINANCIAL COMPANIES LLLP	0%
SBI Securities Co Ltd	0%
Pflug Koory, LLC.	0.01%
Citadel Advisors Llc	0.24%
TWO SIGMA SECURITIES, LLC	0.14%

See all

Insights on Silexion Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 491.1% return, outperforming this stock by 590.5%
NEGATIVE IMPACT
Price Dip
In the last 7 days, SLXN stock has moved down by -7.9%

About Silexion Therapeutics

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.

Organisation	Silexion Therapeutics
Headquarters	The Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel, 9112001
Industry	Biotechnology
CEO	Mr. Ilan Hadar M.B.A.
E-voting on shares	Click here to vote

Key Management of Silexion Therapeutics

Name	Title
Mr. Ilan Hadar M.B.A.	Chairman & CEO
Ms. Mirit Horenshtein Hadar	EVP of Finance Affairs, CFO & Secretary
Dr. Mitchell Shirvan M.B.A., Ph.D.	Chief Scientific & Development Officer

FAQs

What is Silexion Therapeutics share price today?

Silexion Therapeutics share price today is $0.41 as on August 19, 2026 at 9:37 pm IST. Silexion Therapeutics share today touched a day high of $0.41 and a low of $0.40.

What is the 52 week high and 52 week low for Silexion Therapeutics share?

Silexion Therapeutics share touched a 52 week high of $80.00 on August 29, 2025 and a 52 week low of $0.37 on August 14, 2026. Silexion Therapeutics stock price today i.e. August 19, 2026 at 9:37 pm IST is trending at $0.41,which is 99.49% down from its 52 week high and 9.22% up from its 52 week low.

What is Silexion Therapeutics's market capitalisation today?

Silexion Therapeutics market capitalisation is $0.00T as on August 19, 2026 at 9:37 pm IST.

How to invest in Silexion Therapeutics Stock (SLXN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Silexion Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Silexion Therapeutics Shares that will get you 3.6819 shares as per Silexion Therapeutics share price of $0.41 per share as on August 19, 2026 at 9:37 pm IST.

What is the minimum amount required to buy Silexion Therapeutics Stock (SLXN) from India?

Indian investors can start investing in Silexion Therapeutics (SLXN) shares with as little as ₹95.743 or $1 (as of August 19, 2026 at 9:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in Silexion Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 19, 2026 at 9:37 pm IST). Based on Silexion Therapeutics share’s latest price of $0.41 as on August 19, 2026 at 9:37 pm IST, you will get 24.5459 shares of Silexion Therapeutics. Learn more about fractional shares .